Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine

Haemodialysis (HD) is a life-sustaining treatment for patients with end-stage renal disease (ESRD). HD can bring about significant impairment in health-related quality of life (HRQOL) and outcomes. Therefore, we sought to describe the patterns of HRQOL and determine the independent factors associate...

Full description

Saved in:
Bibliographic Details
Published in:BMC nephrology 2016-04, Vol.17 (1), p.44, Article 44
Main Authors: Zyoud, Sa'ed H, Daraghmeh, Dala N, Mezyed, Diana O, Khdeir, Razan L, Sawafta, Mayas N, Ayaseh, Nora A, Tabeeb, Ghada H, Sweileh, Waleed M, Awang, Rahmat, Al-Jabi, Samah W
Format: Article
Language:English
Subjects:
Adult
Aged
Arabs - psychology
Care and treatment
Chronic kidney failure
Complications and side effects
Cross-Sectional Studies
Female
Health aspects
Hemodialysis
Humans
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - psychology
Kidney Failure, Chronic - therapy
Male
Middle Aged
Middle East - epidemiology
Nephrology
Observational studies
Pilot Projects
Quality of Life - psychology
Renal Dialysis - psychology
Renal Dialysis - trends
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Haemodialysis (HD) is a life-sustaining treatment for patients with end-stage renal disease (ESRD). HD can bring about significant impairment in health-related quality of life (HRQOL) and outcomes. Therefore, we sought to describe the patterns of HRQOL and determine the independent factors associated with poor HRQOL in Palestinian patients on HD. A multicenter cross-sectional study was performed from June 2014 to January 2015 using the EuroQOL-5 Dimensions instrument (EQ-5D-5L) for the assessment of HRQOL. ESRD patients undergoing HD in all dialysis centres in the West Bank of Palestine were approached and recruited for this study. Multiple linear regression was carried out to identify factors that were significantly associated with HRQOL. Two hundred and sixty-seven patients were participated in the current study giving response rate of 96 %. Overall, 139 (52.1 %) were male, and the mean ± standard deviation age was 53.3 ± 16.2 years. The reported HRQOL as measured by mean EQ-5D-5L index value and Euro QOL visual analogue scale (EQ-VAS) score was 0.37 ± 0.44 and 59.38 ± 45.39, respectively. There was a moderate positive correlation between the EQ-VAS and the EQ-5D-5L index value (r = 0.42, p 
ISSN:1471-2369
1471-2369
DOI:10.1186/s12882-016-0257-z